VSee Health (VSEE)
Remote acute-care physician services and clinical technology for institutional settings.
Something off on this page? Send us feedback.
Provides acute-care telehealth services that pair remote specialist physicians with integrated clinical technology for hospitals and institutional settings. Revenue comes from patient, telehealth, and institutional fees, while the post-divestiture business is centered on the retained iDoc operation.
Delivers acute-care telehealth services through iDoc, supplying remote specialist physicians and supporting virtual-care technology to hospitals, other healthcare facilities, and the federal prison system. Its services span virtual ICU coverage, critical care, neurology, neurocritical care, EEG interpretation, tele-radiology, and specialist e-consults for correctional facilities.
Combines a network of board-certified physicians with an internally developed platform for secure video, EHR and billing functions, dashboards, vital-sign interfaces, messaging, and handoffs. Revenue comes from patient fees, contracted telehealth services, institutional fees, and generally fixed monthly contracts covering physician hours plus agreed service rates.
Operates principally in the United States after selling its VSee Lab software business, retaining iDoc and a minority GoMyRx interest. Service delivery depends on hospital relationships, licensed physicians, reimbursement, clinical and privacy rules, and cloud and telecommunications infrastructure.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $454.2K · Total debt $1.9M · Total assets $16.7M · Shareholders' equity $7.6M
- Revenue
- $1.6M
- Operating income
- −$2.7M
- Net income
- −$3.1M
No dividends on record.
| Institutions12 holders · as of Mar 31, 2026 | ≥ 7.83% | 4.44M shares | |
| Insiders7 holders · as of Mar 24, 2026 | 7.40% | 4.19M shares | |
| Otherremainder | ≤ 84.77% | 48.05M shares |
56.68M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (56.68M in the company's Sep 3, 2026 report, 16.26M elsewhere); stakes use the report.
Institutional filings for VSEEW (100% of the company) are not on file here, so the institutional figure is a floor.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Armistice Capital, LLCInstitution | 6.17% | 3.50M | 13Fas of Mar 31, 2026 |
David L. WickershamInsiderdirector | 4.12% | 2.34M | Form 4filed Mar 5, 2026 ↗ |
Jerry LeonardInsiderofficer: Chief Financial Officer | 1.25% | 710,938 | Form 4filed Mar 24, 2026 ↗ |
Lawrence M. Sands1Insider10 percent owner | 1.24% | 705,000 | Form 4filed Nov 19, 2024 ↗ |
Geode Capital Management, LLCInstitution | 0.77% | 437,599 | 13Fas of Mar 31, 2026 |
| See all 25 → | |||
- Reported at 2.90% on Dec 4, 2025, under the 5% line, so no further filing is required.
13F — a manager's quarterly holdings · Form 4 — an insider's transaction report
Insider tradesForm 4
No open-market trades in the last 12 months.
- Amwell
Health-system virtual-care platform and specialty-network rival.
- Teladoc Health
Scaled virtual-care platform and provider-network rival.
- Ceribell
Point-of-care EEG and AI brain-monitoring rival in neurocritical care.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| VSee Health | $0.0169 | +5.63% | $274.9K | — | — | 0.0 | −59.5% |
| Amwell | $12.92 | +0.71% | $218.2M | — | — | 1.0 | −26.6% |
| Teladoc Health | $6.50 | +0.70% | $1.17B | — | — | 0.5 | −4.0% |
| Ceribell | $24.82 | +0.98% | $941.4M | — | — | 9.2 | +32.5% |
| Median | — | — | 1.0 | −4.0% |